DR Reddys Laboratories Ltd SEC filings RDY
DR Reddys Laboratories Ltd has 1,002 filings in SEC EDGAR's recent list, going back to Feb 14, 2017. Its latest annual report, Form 20-F, was filed on May 29, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 144 | Notice of proposed sale | Nov 2, 2026 | — |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Apr 1, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 27, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 27, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 27, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 27, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 27, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 27, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 20, 2026 | Dec 18, 2025 |
| 3 | Initial insider ownership | Mar 20, 2026 | Dec 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 28, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 144 | Notice of proposed sale | Jul 29, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 1, 2024 | — |
| 144 | Notice of proposed sale | Oct 27, 2023 | — |
| 144 | Notice of proposed sale | Jul 27, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 2, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 2, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 9, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 10, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Sep 9, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Jan 17, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2018 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 18, 2017 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 14, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2017 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RDY (NYSE)
- Fiscal year ends
- March 31
- Incorporated in
- India
- Headquarters
- Hyderabad
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1135951
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.